Ginkgo Bioworks Holdings, Inc.

NYSE (USD): Ginkgo Bioworks Holdings, Inc. (DNA)

Last Price

10.08

Today's Change

+1.34 (15.33%)

Day's Change

8.40 - 10.53

Trading Volume

2,616,130

Profile
DNA

Exchange:  New York Stock Exchange New York Stock Exchange

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Dr. Jason Kelly Ph.D. Dr. Jason Kelly Ph.D.

Full Time Employees:  1,218 1,218

IPO Date:  2021-04-19 2021-04-19

CIK:  0001830214 0001830214

ISIN:  US37611X1000 US37611X1000

CUSIP:  37611X100 37611X100

Beta:  1.10 1.10

Last Dividend:  0.00 0.00

Dcf Diff:  15.95 15.95

Dcf:  -7.93 -7.93

Description

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Address

27 Drydock Avenue,
Boston, MA 02210, US

877 422 5362

http://www.ginkgobioworks.com

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment